Kinga Kościołek
Research Subjects
Kinga Kościołek has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Julia Kaczmarek
Independent Public Healthcare Institution MSWiA in Lodz, Poland
8 shared publications - Agnieszka Olejnik
Independent Public Healthcare Institution MSWiA in Lodz, Poland
5 shared publications - Beata Huszcza
Dr. Karol Jonscher Municipal Medical Center in Lodz, Milionowa Street 14, 93-113 Łódź, Poland
5 shared publications - Dominik Gajewski
St. John of God Brothers Hospitaller Hospital in Lodz, Poland
5 shared publications - Jakub Grandos
St. John of God Brothers Hospitaller Hospital in Lodz, Poland
5 shared publications - Konrad Gronek
Independent Public Healthcare Institution MSWiA in Lodz, Poland
5 shared publications
Latest Publications
- Open Access
- 17 August 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 69
Habitual Physical Activity and Structured Exercise in Premenstrual Syndrome: A Narrative Review of Observational and Interventional Evidence
Background: Premenstrual syndrome (PMS) is a cyclic condition with physical, affective and behavioural symptoms that may impair functioning and quality of life. Habitual physical activity and structured exercise are distinct exposures. Aim: To distinguish these exposures, synthesise observational and interventional evidence, and assess clinical implications and methodological limitations. Material and Methods: This structured narrative review searched PubMed and Scopus, with Google Scholar supplementary, for English-language publications from January 2011 to 1 June 2026. Both evidence streams were synthesised separately, considering design, PMS ascertainment, programme characteristics, outcomes and methodological limitations. Results: Observational evidence was mixed, with inverse, null and possible non-linear associations. Measurement and ascertainment differences, confounding, reverse causality and uncertain temporality limited causal interpretation. Interventional findings were broadly favourable but heterogeneous across aerobic, mind-body and strengthening programmes. Global PMS outcomes were not interchangeable with pain, stress or biomarkers. Confidence was limited by selected samples, varied comparators, inconsistent reporting and limited follow-up. Conclusion: Habitual physical activity and structured exercise are not interchangeable, and observational evidence does not support a prevention claim. Evidence did not support modality ranking or a precise prescription. Structured exercise may be an individualised adjunct but should not replace diagnosis or established care; severe, persistent, functionally impairing or atypical symptoms require clinical assessment. Future studies need standardised PMS confirmation, syndrome-wide outcomes and transparent programme, safety and follow-up reporting.
- 17 August 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 69
Open AccessHabitual Physical Activity and Structured Exercise in Premenstrual Syndrome: A Narrative Review of Observational and Interventional Evidence
Background: Premenstrual syndrome (PMS) is a cyclic condition with physical, affective and behavioural symptoms that may impair functioning and quality of life. Habitual physical activity and structured exercise are distinct exposures. Aim: To distinguish these exposures, synthesise observational and interventional evidence, and assess clinical implications and methodological limitations. Material and Methods: This structured narrative review searched PubMed and Scopus, with Google Scholar supplementary, for English-language publications from January 2011 to 1 June 2026. Both evidence streams were synthesised separately, considering design, PMS ascertainment, programme characteristics, outcomes and methodological limitations. Results: Observational evidence was mixed, with inverse, null and possible non-linear associations. Measurement and ascertainment differences, confounding, reverse causality and uncertain temporality limited causal interpretation. Interventional findings were broadly favourable but heterogeneous across aerobic, mind-body and strengthening programmes. Global PMS outcomes were not interchangeable with pain, stress or biomarkers. Confidence was limited by selected samples, varied comparators, inconsistent reporting and limited follow-up. Conclusion: Habitual physical activity and structured exercise are not interchangeable, and observational evidence does not support a prevention claim. Evidence did not support modality ranking or a precise prescription. Structured exercise may be an individualised adjunct but should not replace diagnosis or established care; severe, persistent, functionally impairing or atypical symptoms require clinical assessment. Future studies need standardised PMS confirmation, syndrome-wide outcomes and transparent programme, safety and follow-up reporting.
- Open Access
- 5 August 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 65
The Influence of Sport and Structured Exercise in Prostate Cancer Management: Recommended Modalities and Narrative Review
Prostate cancer is one of the most common malignancies among men, with a steadily increasing global incidence. Over recent decades, major advances in imaging techniques and therapeutic strategies have significantly improved diagnostic accuracy and survival outcomes. Nevertheless, treatment-related adverse effects remain a substantial clinical challenge and frequently impair patients’ quality of life. This review summarizes current diagnostic approaches and treatment modalities for prostate cancer, with a particular emphasis on the influence of sport and structured exercise recommendations as supportive interventions. Exercise has been shown to improve physical function, reduce fatigue, and enhance quality of life during and after treatment.In the setting of radical prostatectomy, both preoperative and postoperative exercise interventions, particularly pelvic floor muscle training, accelerate functional recovery and reduce urinary incontinence. In patients undergoing androgen deprivation therapy, physical activity, especially resistance training, effectively counteracts treatment-related adverse effects, including loss of muscle mass, increased adiposity, fatigue, and psychological disturbances. Although current evidence regarding the association between physical activity and reduced prostate cancer risk remains inconclusive, emerging data suggest that exercise may positively influence disease progression and survival outcomes. Physical activity should therefore be considered an integral component of comprehensive prostate cancer care. Further studies are required to establish standardized and evidence-based exercise guidelines for this patient population.
- 5 August 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 65
Open AccessThe Influence of Sport and Structured Exercise in Prostate Cancer Management: Recommended Modalities and Narrative Review
Prostate cancer is one of the most common malignancies among men, with a steadily increasing global incidence. Over recent decades, major advances in imaging techniques and therapeutic strategies have significantly improved diagnostic accuracy and survival outcomes. Nevertheless, treatment-related adverse effects remain a substantial clinical challenge and frequently impair patients’ quality of life. This review summarizes current diagnostic approaches and treatment modalities for prostate cancer, with a particular emphasis on the influence of sport and structured exercise recommendations as supportive interventions. Exercise has been shown to improve physical function, reduce fatigue, and enhance quality of life during and after treatment.In the setting of radical prostatectomy, both preoperative and postoperative exercise interventions, particularly pelvic floor muscle training, accelerate functional recovery and reduce urinary incontinence. In patients undergoing androgen deprivation therapy, physical activity, especially resistance training, effectively counteracts treatment-related adverse effects, including loss of muscle mass, increased adiposity, fatigue, and psychological disturbances. Although current evidence regarding the association between physical activity and reduced prostate cancer risk remains inconclusive, emerging data suggest that exercise may positively influence disease progression and survival outcomes. Physical activity should therefore be considered an integral component of comprehensive prostate cancer care. Further studies are required to establish standardized and evidence-based exercise guidelines for this patient population.
- Open Access
- 4 August 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 65, 73987
Diabetic Peripheral Neuropathy – From Early Symptoms to Long-Term Complications and Treatment Strategies
Introduction:Diabetic peripheral neuropathy (DPN) is a common diabetes complication causing sensory dysfunction, neuropathic pain, gait impairment, foot ulcers, amputation risk, and lower quality of life; it may initially be silent or hard to recognize. Aim of the study:This review synthesized knowledge on DPN symptoms, pathophysiology, diagnosis, complications, treatment, prevention, and future directions. Materials and methods:Relevant sources were identified through PubMed and Google Scholar; this article was prepared as a narrative review, not a systematic review or meta-analysis. Results:DPN is a multifactorial, progressive, length-dependent sensorimotor polyneuropathy involving metabolic, vascular, inflammatory, oxidative, mitochondrial, and neuroglial mechanisms. Hyperglycemia, dyslipidemia, obesity, insulin resistance, microvascular injury, and genetics may damage nerve fibers. Manifestations include pain, sensory symptoms, impaired protective sensation, gait instability, deformity, ulceration, amputation risk, sleep disturbance, emotional burden, and reduced functioning. Management includes metabolic control, screening, foot protection, pain therapy, rehabilitation, lifestyle change, education, and emerging therapies, but current treatment mainly relieves symptoms and cannot reliably reverse established nerve damage. Conclusions:DPN requires early recognition, individualized assessment, realistic goals, and multidisciplinary care targeting pain, foot safety, mobility, function, and quality of life. Research should validate biomarkers, improve risk stratification, and develop disease-modifying therapies.
- 4 August 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 65, 73987
Open AccessDiabetic Peripheral Neuropathy – From Early Symptoms to Long-Term Complications and Treatment Strategies
Introduction:Diabetic peripheral neuropathy (DPN) is a common diabetes complication causing sensory dysfunction, neuropathic pain, gait impairment, foot ulcers, amputation risk, and lower quality of life; it may initially be silent or hard to recognize. Aim of the study:This review synthesized knowledge on DPN symptoms, pathophysiology, diagnosis, complications, treatment, prevention, and future directions. Materials and methods:Relevant sources were identified through PubMed and Google Scholar; this article was prepared as a narrative review, not a systematic review or meta-analysis. Results:DPN is a multifactorial, progressive, length-dependent sensorimotor polyneuropathy involving metabolic, vascular, inflammatory, oxidative, mitochondrial, and neuroglial mechanisms. Hyperglycemia, dyslipidemia, obesity, insulin resistance, microvascular injury, and genetics may damage nerve fibers. Manifestations include pain, sensory symptoms, impaired protective sensation, gait instability, deformity, ulceration, amputation risk, sleep disturbance, emotional burden, and reduced functioning. Management includes metabolic control, screening, foot protection, pain therapy, rehabilitation, lifestyle change, education, and emerging therapies, but current treatment mainly relieves symptoms and cannot reliably reverse established nerve damage. Conclusions:DPN requires early recognition, individualized assessment, realistic goals, and multidisciplinary care targeting pain, foot safety, mobility, function, and quality of life. Research should validate biomarkers, improve risk stratification, and develop disease-modifying therapies.
- Open Access
- 13 June 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 57, 72608
Beyond the HPG Axis in Relative Energy Deficiency in Sport: Sleep, Psychological Health, and Neuroendocrine Adaptation in Athletes — A Structured Narrative Review
Background: Relative Energy Deficiency in Sport (REDs) is increasingly viewed as a multisystem condition related to problematic low energy availability (LEA), but evidence beyond reproductive and skeletal outcomes is uneven. Objective: To synthesize evidence on sleep, psychological health and neuroendocrine adaptation in athletes with LEA/REDs, while distinguishing established mechanisms from emerging domains. Methods: A structured narrative review with evidence mapping was conducted in PubMed/MEDLINE; 61 full-text records were assessed and synthesized across predefined domains. Findings: The strongest support concerns endocrine and metabolic adaptation, including thyroid, adipokine, somatotropic and stress-axis pathways, although individual markers remain non-specific. Sleep and psychological outcomes are clinically relevant but rely mainly on heterogeneous, mostly observational evidence. Direct neurocognitive evidence in athletes with well-characterized LEA/REDs remains insufficient. Conclusions: REDs should be considered beyond an HPG-centered framework, but claims regarding sleep, psychological health and neurocognition require caution. Future studies should combine objective LEA characterization, longitudinal designs, endocrine profiling, sleep assessment and direct cognitive testing.
- 13 June 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 57, 72608
Open AccessBeyond the HPG Axis in Relative Energy Deficiency in Sport: Sleep, Psychological Health, and Neuroendocrine Adaptation in Athletes — A Structured Narrative Review
Background: Relative Energy Deficiency in Sport (REDs) is increasingly viewed as a multisystem condition related to problematic low energy availability (LEA), but evidence beyond reproductive and skeletal outcomes is uneven. Objective: To synthesize evidence on sleep, psychological health and neuroendocrine adaptation in athletes with LEA/REDs, while distinguishing established mechanisms from emerging domains. Methods: A structured narrative review with evidence mapping was conducted in PubMed/MEDLINE; 61 full-text records were assessed and synthesized across predefined domains. Findings: The strongest support concerns endocrine and metabolic adaptation, including thyroid, adipokine, somatotropic and stress-axis pathways, although individual markers remain non-specific. Sleep and psychological outcomes are clinically relevant but rely mainly on heterogeneous, mostly observational evidence. Direct neurocognitive evidence in athletes with well-characterized LEA/REDs remains insufficient. Conclusions: REDs should be considered beyond an HPG-centered framework, but claims regarding sleep, psychological health and neurocognition require caution. Future studies should combine objective LEA characterization, longitudinal designs, endocrine profiling, sleep assessment and direct cognitive testing.
- Open Access
- 16 April 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 54
The Role of Physical Activity in Lower Extremity Peripheral Artery Disease.
Peripheral artery disease (PAD) is a common disorder characterised by a reduced blood circulation caused by stenosis or occlusion of peripheral arteries of the limbs, predominantly affecting the lower extremities. This condition is typically related to atherosclerosis, but it might also be caused by vasculitis, fibromuscular dysplasia, or adventitial cystic disease. Although atherosclerotic occlusive disease of the lower extremities has high mortality and morbidity rates, it remains underdiagnosed and undertreated condition. The risk factors of PAD are similar to those for coronary and cerebrovascular disease. The most common symptom of PAD is intermittent claudication, but recent studies show that asymptomatic PAD is several times more common in the population than intermittent claudication. The medical approach to peripheral artery disease is multifaceted and includes smoking cessation, lipid-lowering therapy, antiplatelet therapy, antithrombotic therapy, peripheral vasodilators, blood pressure management, glycemic control and various methods of revascularization. An important, although frequently neglected aspect is an exercise therapy. Walking exercise is first-line therapy for PAD-related walking impairment. Supervised walking exercise and structured home-based walking exercise each not only improve walking ability, but also have other benefits, which we would like to discuss in this review.
- 16 April 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 54
Open AccessThe Role of Physical Activity in Lower Extremity Peripheral Artery Disease.
Peripheral artery disease (PAD) is a common disorder characterised by a reduced blood circulation caused by stenosis or occlusion of peripheral arteries of the limbs, predominantly affecting the lower extremities. This condition is typically related to atherosclerosis, but it might also be caused by vasculitis, fibromuscular dysplasia, or adventitial cystic disease. Although atherosclerotic occlusive disease of the lower extremities has high mortality and morbidity rates, it remains underdiagnosed and undertreated condition. The risk factors of PAD are similar to those for coronary and cerebrovascular disease. The most common symptom of PAD is intermittent claudication, but recent studies show that asymptomatic PAD is several times more common in the population than intermittent claudication. The medical approach to peripheral artery disease is multifaceted and includes smoking cessation, lipid-lowering therapy, antiplatelet therapy, antithrombotic therapy, peripheral vasodilators, blood pressure management, glycemic control and various methods of revascularization. An important, although frequently neglected aspect is an exercise therapy. Walking exercise is first-line therapy for PAD-related walking impairment. Supervised walking exercise and structured home-based walking exercise each not only improve walking ability, but also have other benefits, which we would like to discuss in this review.
- Open Access
- 19 March 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 53, 69507
Genetic Determinants of Inter-Individual Variability in Statin Therapy
Statins, or HMG-CoA reductase inhibitors, represent one of the most extensively researched and frequently prescribed pharmacological agents, primarily utilized to reduce cardiovascular risk through the modulation of serum cholesterol levels. Although their efficacy in reducing global mortality and cardiovascular events is well-established, genetic variability persists among different populations which may predispose patients to dose-related adverse effects and reduced efficancy of statin therapy. This heterogeneity has driven a shift in the scientific landscape toward exploring common genetic polymorphisms within the genes encoding genes involved in pharmacodynamic pathways. This review aims to provide a comprehensive analysis of clinically significant polymorphisms within the pharmacodynamic pathways of statins. Methods: A systematic literature review was conducted in accordance with PRISMA guidelines. Databases including PubMed, Embase, and the Cochrane Library were searched for peer-reviewed publications from 2021 to 2025. Following a rigorous selection process based on Evidence-Based Medicine (EBM) criteria. Conclusions: Despite rapid progress in the field of pharmacogenomics, the role of genetic polymorphisms among genes involved in pharmacodynamic pathways of statin therapy still requires more research in order to establish robust evidence of their role in the overall lipid-lowering efficacy of statins.
- 19 March 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 53, 69507
Open AccessGenetic Determinants of Inter-Individual Variability in Statin Therapy
Statins, or HMG-CoA reductase inhibitors, represent one of the most extensively researched and frequently prescribed pharmacological agents, primarily utilized to reduce cardiovascular risk through the modulation of serum cholesterol levels. Although their efficacy in reducing global mortality and cardiovascular events is well-established, genetic variability persists among different populations which may predispose patients to dose-related adverse effects and reduced efficancy of statin therapy. This heterogeneity has driven a shift in the scientific landscape toward exploring common genetic polymorphisms within the genes encoding genes involved in pharmacodynamic pathways. This review aims to provide a comprehensive analysis of clinically significant polymorphisms within the pharmacodynamic pathways of statins. Methods: A systematic literature review was conducted in accordance with PRISMA guidelines. Databases including PubMed, Embase, and the Cochrane Library were searched for peer-reviewed publications from 2021 to 2025. Following a rigorous selection process based on Evidence-Based Medicine (EBM) criteria. Conclusions: Despite rapid progress in the field of pharmacogenomics, the role of genetic polymorphisms among genes involved in pharmacodynamic pathways of statin therapy still requires more research in order to establish robust evidence of their role in the overall lipid-lowering efficacy of statins.
- Open Access
- 15 March 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (1(49))
THE EVOLUTION OF AI MEDICAL CONSULTANTS AND THEIR IMPACT ON PATIENT EDUCATION: A LITERATURE REVIEW
Background: The rapid development of Artificial Intelligence (AI) has led to its transition from a theoretical concept in informatics to a functional clinical tool. This study evaluates the impact of AI-based consultants and Large Language Models (LLMs) on patient health literacy and the quality of medical education within the framework of contemporary healthcare standards. Methods: A systematic literature review was conducted in accordance with PRISMA guidelines. Databases including PubMed, Embase, and the Cochrane Library were searched for peer-reviewed publications from 2021 to 2025. Following a rigorous selection process based on Evidence-Based Medicine (EBM) criteria, 31 key sources were identified and synthesized. Results: LLMs significantly improve the comprehensibility of clinical terminology by adapting medical content to a 9th-11th-grade literacy level. Digital feedback systems, such as the KidneyOnline platform, demonstrate superior efficacy in improving patient adherence compared with standard protocols. However, several critical limitations were identified, including hallucination bias (fabrication of clinical data), a “readability floor” phenomenon associated with up to 83% content reduction, and the risk of professional deskilling among clinicians. Furthermore, wearable devices such as the Apple Watch show high correlation (r=0.92) with medical-grade pulse oximetry, offering new perspectives for real-time health monitoring. Conclusions: AI represents a transformative yet socially consequential innovation in patient education and health literacy. Its responsible implementation requires a strict human-in-the-loop model to ensure clinical safety, ethical accountability, and equitable access. Systematic verification of AI-generated medical information by qualified healthcare professionals remains essential to maintain both high standards of care and public trust in digital health innovations.
- 15 March 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (1(49))
Open AccessTHE EVOLUTION OF AI MEDICAL CONSULTANTS AND THEIR IMPACT ON PATIENT EDUCATION: A LITERATURE REVIEW
Background: The rapid development of Artificial Intelligence (AI) has led to its transition from a theoretical concept in informatics to a functional clinical tool. This study evaluates the impact of AI-based consultants and Large Language Models (LLMs) on patient health literacy and the quality of medical education within the framework of contemporary healthcare standards. Methods: A systematic literature review was conducted in accordance with PRISMA guidelines. Databases including PubMed, Embase, and the Cochrane Library were searched for peer-reviewed publications from 2021 to 2025. Following a rigorous selection process based on Evidence-Based Medicine (EBM) criteria, 31 key sources were identified and synthesized. Results: LLMs significantly improve the comprehensibility of clinical terminology by adapting medical content to a 9th-11th-grade literacy level. Digital feedback systems, such as the KidneyOnline platform, demonstrate superior efficacy in improving patient adherence compared with standard protocols. However, several critical limitations were identified, including hallucination bias (fabrication of clinical data), a “readability floor” phenomenon associated with up to 83% content reduction, and the risk of professional deskilling among clinicians. Furthermore, wearable devices such as the Apple Watch show high correlation (r=0.92) with medical-grade pulse oximetry, offering new perspectives for real-time health monitoring. Conclusions: AI represents a transformative yet socially consequential innovation in patient education and health literacy. Its responsible implementation requires a strict human-in-the-loop model to ensure clinical safety, ethical accountability, and equitable access. Systematic verification of AI-generated medical information by qualified healthcare professionals remains essential to maintain both high standards of care and public trust in digital health innovations.
- Open Access
- 7 March 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 52, 69424
Antidepressant Pharmacotherapy and Structured Physical Activity in Major Depressive Disorder: Implications for Functional Capacity and Cardiometabolic Health
Major depressive disorder (MDD) is a multidimensional condition associated not only with affective symptoms but also with reduced physical activity, impaired functional capacity, and increased cardiometabolic risk. Beyond mood disturbance, depression is frequently accompanied by decreased cardiorespiratory fitness, altered body composition, and autonomic dysregulation. While antidepressant pharmacotherapy remains a cornerstone of treatment, structured physical activity has emerged as a clinically relevant intervention within sports and lifestyle medicine. Evidence from recent meta-analyses and network meta-analyses demonstrates moderate antidepressant effects of aerobic and resistance-based exercise interventions. Comparative analyses suggest similar efficacy of exercise and pharmacotherapy in mild-to-moderate depression, with structured training providing additional benefits for cardiovascular performance, metabolic regulation, and functional recovery. The bidirectional relationship between depression and metabolic syndrome further underscores the importance of addressing systemic risk factors alongside psychiatric symptoms. Antidepressant agents differ in their metabolic, autonomic, and endocrine profiles, with potential implications for weight regulation, insulin sensitivity, and exercise adherence. Overlapping biological mechanisms between pharmacotherapy and physical training include monoaminergic modulation, neuroplasticity enhancement through brain-derived neurotrophic factor pathways, and attenuation of systemic inflammation. However, direct randomized comparisons of combined pharmacotherapy and structured exercise remain limited. An individualized treatment model integrating pharmacological stabilization with progressive physical training may optimize both psychological recovery and longterm physiological resilience in patients with major depressive disorder.
- 7 March 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 52, 69424
Open AccessAntidepressant Pharmacotherapy and Structured Physical Activity in Major Depressive Disorder: Implications for Functional Capacity and Cardiometabolic Health
Major depressive disorder (MDD) is a multidimensional condition associated not only with affective symptoms but also with reduced physical activity, impaired functional capacity, and increased cardiometabolic risk. Beyond mood disturbance, depression is frequently accompanied by decreased cardiorespiratory fitness, altered body composition, and autonomic dysregulation. While antidepressant pharmacotherapy remains a cornerstone of treatment, structured physical activity has emerged as a clinically relevant intervention within sports and lifestyle medicine. Evidence from recent meta-analyses and network meta-analyses demonstrates moderate antidepressant effects of aerobic and resistance-based exercise interventions. Comparative analyses suggest similar efficacy of exercise and pharmacotherapy in mild-to-moderate depression, with structured training providing additional benefits for cardiovascular performance, metabolic regulation, and functional recovery. The bidirectional relationship between depression and metabolic syndrome further underscores the importance of addressing systemic risk factors alongside psychiatric symptoms. Antidepressant agents differ in their metabolic, autonomic, and endocrine profiles, with potential implications for weight regulation, insulin sensitivity, and exercise adherence. Overlapping biological mechanisms between pharmacotherapy and physical training include monoaminergic modulation, neuroplasticity enhancement through brain-derived neurotrophic factor pathways, and attenuation of systemic inflammation. However, direct randomized comparisons of combined pharmacotherapy and structured exercise remain limited. An individualized treatment model integrating pharmacological stabilization with progressive physical training may optimize both psychological recovery and longterm physiological resilience in patients with major depressive disorder.